Simona Parisi, Claudio Gambardella, Francesco Iovino, Roberto Ruggiero, Francesco Saverio Lucido, Giusiana Nesta, Salvatore Tolone, Luigi Brusciano, Francesca Fisone, Federico Maria Mongardini, Giovanni Cozzolino, Carminia Maria Della Corte, Stefania Napolitano, Michele Orditura, Rosetta Esposito, Ludovico Docimo
Breast angiosarcoma is a rare malignancy, accounting for less than 1% of all soft tissue cancers. It comprises primitive and secondary subtypes, such as radiogenic breast angiosarcoma (RAS). Despite multimodal treatment, angiosarcomas represent an incurable disease for many patients and a significant cause of deterioration in their quality of life. Surgery is a cornerstone in management, but high recurrence rates are reported. Electrochemotherapy (ECT) is a practicable locoregional treatment for patients with advanced angiosarcoma as part of a multimodal therapeutic strategy...
January 18, 2024: Journal of Clinical Medicine